Numerous preclinical studies (in vitro and animal models) have demonstrated the anticancer properties of EGCG. However, clinical trials in humans are still ongoing and the results have been mixed. While some studies have shown promising results, others have not found significant benefits. Therefore, more rigorous clinical trials are needed to confirm the efficacy of EGCG in cancer prevention and treatment.
